# ADT Inc.: financial statements, quarterly

ADT · NYSE · CIK 1703056 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/adt.md) · [Financials](/companies/adt/financials.md) · [Filings](/companies/adt/filings.md) · [Insiders](/companies/adt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/adt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,180](/filings/0001703056-25-000022.md) | [1,172](/filings/0001703056-25-000022.md) | [1,190](/filings/0001703056-25-000069.md) | [1,205](/filings/0001703056-25-000139.md) | [1,244](/filings/0001703056-25-000166.md) | [1,260](/filings/0001703056-25-000022.md) | [1,267](/filings/0001703056-26-000059.md) | [1,287](/filings/0001703056-26-000100.md) | [1,298](/filings/0001703056-25-000166.md) | [1,276 d](/filings/0001703056-26-000022.md) | [1,279](/filings/0001703056-26-000059.md) | [1,312](/filings/0001703056-26-000100.md) |
| Selling, general and administrative | $m | [346](/filings/0001703056-24-000107.md) | [386 d](/filings/0001703056-26-000022.md) | [370](/filings/0001703056-25-000069.md) | [390](/filings/0001703056-25-000139.md) | [360](/filings/0001703056-25-000166.md) | [380 d](/filings/0001703056-26-000022.md) | [369](/filings/0001703056-26-000059.md) | [356](/filings/0001703056-26-000100.md) | [384](/filings/0001703056-25-000166.md) | [360 d](/filings/0001703056-26-000022.md) | [365](/filings/0001703056-26-000059.md) | [386](/filings/0001703056-26-000100.md) |
| Operating income | $m | [307](/filings/0001703056-25-000022.md) | [307](/filings/0001703056-25-000022.md) | [292](/filings/0001703056-25-000069.md) | [284](/filings/0001703056-25-000139.md) | [326](/filings/0001703056-25-000166.md) | [305](/filings/0001703056-25-000022.md) | [319](/filings/0001703056-26-000059.md) | [342](/filings/0001703056-26-000100.md) | [315](/filings/0001703056-25-000166.md) | [333 d](/filings/0001703056-26-000022.md) | [325](/filings/0001703056-26-000059.md) | [316](/filings/0001703056-26-000100.md) |
| Income tax | $m | [34.4](/filings/0001703056-24-000107.md) | [40.6 d](/filings/0001703056-26-000022.md) | [56.4](/filings/0001703056-25-000069.md) | [59.8](/filings/0001703056-25-000139.md) | [50.2](/filings/0001703056-25-000166.md) | [29.3 d](/filings/0001703056-26-000022.md) | [51.0](/filings/0001703056-26-000059.md) | [58.7](/filings/0001703056-26-000100.md) | [55.1](/filings/0001703056-25-000166.md) | [68.4 d](/filings/0001703056-26-000022.md) | [58.1](/filings/0001703056-26-000059.md) | [60.8](/filings/0001703056-26-000100.md) |
| Net income | $m | [(86.2)](/filings/0001703056-25-000022.md) | [576](/filings/0001703056-25-000022.md) | [91.6](/filings/0001703056-25-000069.md) | [92.4](/filings/0001703056-25-000139.md) | [127](/filings/0001703056-25-000166.md) | [190](/filings/0001703056-25-000022.md) | [140](/filings/0001703056-26-000059.md) | [165](/filings/0001703056-26-000100.md) | [145](/filings/0001703056-25-000166.md) | [145 d](/filings/0001703056-26-000022.md) | [168](/filings/0001703056-26-000059.md) | [154](/filings/0001703056-26-000100.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001703056-23-000187.md) | [0.0](/filings/0001703056-26-000022.md) | [0.0](/filings/0001703056-24-000051.md) | [0.0](/filings/0001703056-24-000089.md) | [0.1](/filings/0001703056-24-000107.md) | [0.1](/filings/0001703056-26-000022.md) | [0.0](/filings/0001703056-25-000069.md) | [0.0](/filings/0001703056-25-000139.md) | [0.1](/filings/0001703056-25-000166.md) | [0.1](/filings/0001703056-26-000100.md) | [0.1](/filings/0001703056-26-000059.md) | [0.0](/filings/0001703056-26-000100.md) |
| Current assets | $bn | [1.6](/filings/0001703056-23-000187.md) | [1.0](/filings/0001703056-25-000022.md) | [1.0](/filings/0001703056-24-000051.md) | [1.0](/filings/0001703056-24-000089.md) | [1.0](/filings/0001703056-24-000107.md) | [1.0](/filings/0001703056-26-000022.md) | [0.9](/filings/0001703056-25-000069.md) | [0.9](/filings/0001703056-25-000139.md) | [1.0](/filings/0001703056-25-000166.md) | [0.9](/filings/0001703056-26-000100.md) | [0.9](/filings/0001703056-26-000059.md) | [0.8](/filings/0001703056-26-000100.md) |
| Total assets | $bn | [17.4](/filings/0001703056-23-000187.md) | [16.0](/filings/0001703056-25-000022.md) | [15.9](/filings/0001703056-24-000051.md) | [16.0](/filings/0001703056-24-000089.md) | [16.1](/filings/0001703056-24-000107.md) | [16.1](/filings/0001703056-26-000022.md) | [15.8](/filings/0001703056-25-000069.md) | [16.0](/filings/0001703056-25-000139.md) | [16.0](/filings/0001703056-25-000166.md) | [15.8](/filings/0001703056-26-000100.md) | [15.9](/filings/0001703056-26-000059.md) | [15.7](/filings/0001703056-26-000100.md) |
| Current liabilities | $bn | [2.3](/filings/0001703056-23-000187.md) | [1.5](/filings/0001703056-25-000022.md) | [1.4](/filings/0001703056-24-000051.md) | [1.3](/filings/0001703056-24-000089.md) | [1.2](/filings/0001703056-24-000107.md) | [1.3](/filings/0001703056-26-000022.md) | [1.1](/filings/0001703056-25-000069.md) | [2.1](/filings/0001703056-25-000139.md) | [1.5](/filings/0001703056-25-000166.md) | [1.0](/filings/0001703056-26-000100.md) | [1.1](/filings/0001703056-26-000059.md) | [1.1](/filings/0001703056-26-000100.md) |
| Total liabilities | $bn | [14.2](/filings/0001703056-23-000187.md) | [12.2](/filings/0001703056-25-000022.md) | [12.2](/filings/0001703056-24-000051.md) | [12.2](/filings/0001703056-24-000089.md) | [12.2](/filings/0001703056-24-000107.md) | [12.3](/filings/0001703056-26-000022.md) | [12.2](/filings/0001703056-25-000069.md) | [12.3](/filings/0001703056-25-000139.md) | [12.3](/filings/0001703056-25-000166.md) | [12.0](/filings/0001703056-26-000100.md) | [12.1](/filings/0001703056-26-000059.md) | [12.3](/filings/0001703056-26-000100.md) |
| Long-term debt | $bn | [8.8](/filings/0001703056-23-000187.md) | [7.5](/filings/0001703056-25-000022.md) | [7.6](/filings/0001703056-24-000051.md) | [7.5](/filings/0001703056-24-000089.md) | [7.5](/filings/0001703056-24-000107.md) | [7.5](/filings/0001703056-26-000022.md) | [7.6](/filings/0001703056-25-000069.md) | [6.8](/filings/0001703056-25-000139.md) | [7.3](/filings/0001703056-25-000166.md) | [7.4](/filings/0001703056-26-000100.md) | [7.4](/filings/0001703056-26-000059.md) | [7.4](/filings/0001703056-26-000100.md) |
| Current portion of debt | $bn | [0.8](/filings/0001703056-23-000187.md) | [0.3](/filings/0001703056-25-000022.md) | [0.3](/filings/0001703056-24-000051.md) | [0.2](/filings/0001703056-24-000089.md) | [0.2](/filings/0001703056-24-000107.md) | [0.2](/filings/0001703056-26-000022.md) | [0.2](/filings/0001703056-25-000069.md) | [1.1](/filings/0001703056-25-000139.md) | [0.5](/filings/0001703056-25-000166.md) | [0.3](/filings/0001703056-26-000100.md) | [0.3](/filings/0001703056-26-000059.md) | [0.2](/filings/0001703056-26-000100.md) |
| Shareholders' equity | $bn | [3.2](/filings/0001703056-24-000107.md) | [3.8](/filings/0001703056-26-000022.md) | [3.7](/filings/0001703056-25-000139.md) | [3.8](/filings/0001703056-25-000166.md) | [3.9](/filings/0001703056-25-000166.md) | [3.8](/filings/0001703056-26-000100.md) | [3.6](/filings/0001703056-26-000100.md) | [3.7](/filings/0001703056-26-000100.md) | [3.7](/filings/0001703056-25-000166.md) | [3.8](/filings/0001703056-26-000100.md) | [3.8](/filings/0001703056-26-000100.md) | [3.5](/filings/0001703056-26-000100.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [446 d](/filings/0001703056-24-000107.md) | [412 d](/filings/0001703056-26-000022.md) | [364](/filings/0001703056-25-000069.md) | [563 d](/filings/0001703056-25-000139.md) | [498 d](/filings/0001703056-25-000166.md) | [460 d](/filings/0001703056-26-000022.md) | [467](/filings/0001703056-26-000059.md) | [564 d](/filings/0001703056-26-000100.md) | [480 d](/filings/0001703056-25-000166.md) | [374 d](/filings/0001703056-26-000022.md) | [638](/filings/0001703056-26-000059.md) | [666 d](/filings/0001703056-26-000100.md) |
| Capital expenditure | $m | [41.2 d](/filings/0001703056-24-000107.md) | [45.8 d](/filings/0001703056-26-000022.md) | [40.7](/filings/0001703056-25-000069.md) | [46.7 d](/filings/0001703056-25-000139.md) | [42.7 d](/filings/0001703056-25-000166.md) | [33.7 d](/filings/0001703056-26-000022.md) | [45.4](/filings/0001703056-26-000059.md) | [37.6 d](/filings/0001703056-26-000100.md) | [42.6 d](/filings/0001703056-25-000166.md) | [50.1 d](/filings/0001703056-26-000022.md) | [48.9](/filings/0001703056-26-000059.md) | [46.2 d](/filings/0001703056-26-000100.md) |
| Dividends paid | $m | [32.2 d](/filings/0001703056-24-000107.md) | [32.2 d](/filings/0001703056-26-000022.md) | [32.2](/filings/0001703056-25-000069.md) | [50.0 d](/filings/0001703056-25-000139.md) | [50.0 d](/filings/0001703056-25-000166.md) | [50.1 d](/filings/0001703056-26-000022.md) | [48.9](/filings/0001703056-26-000059.md) | [47.1 d](/filings/0001703056-26-000100.md) | [45.8 d](/filings/0001703056-25-000166.md) | [45.0 d](/filings/0001703056-26-000022.md) | [45.0](/filings/0001703056-26-000059.md) | [44.9 d](/filings/0001703056-26-000100.md) |
| Share repurchases | $m | [0.0 d](/filings/0001703056-24-000107.md) | [0.0 d](/filings/0001703056-26-000022.md) | [93.4](/filings/0001703056-25-000069.md) | [0.0 d](/filings/0001703056-25-000139.md) | [0.0 d](/filings/0001703056-25-000166.md) | [147 d](/filings/0001703056-26-000022.md) | [397](/filings/0001703056-26-000059.md) | [98.5 d](/filings/0001703056-26-000100.md) | [112 d](/filings/0001703056-25-000166.md) | [0.0 d](/filings/0001703056-26-000022.md) | [116](/filings/0001703056-26-000059.md) | [484 d](/filings/0001703056-26-000100.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2019 (2019-09-30) | Q3 FY2020 (2020-09-30) | Q1 FY2021 (2021-03-31) | Q1 FY2022 (2022-03-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [740](/filings/0001703056-20-000125.md) | [761](/filings/0001703056-21-000181.md) | [763](/filings/0001703056-22-000126.md) | [911](/filings/0001703056-22-000126.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 760,784,454 at 2020-07-29, from the cover of the [10-Q filed 2020-08-05](/filings/0001703056-20-000107.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.